Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2003, Vol. 8 ›› Issue (4): 431-433.

Previous Articles     Next Articles

Clinical study oflow molecular weight heparins in treatment of chronicPulmonary heart diseases

ZHOU Ai-Lian, CHEN Heng-Hua, TANGliang-Chun   

  1. Department of Respiratory Diseases,Affiliated Hospital of Guangdong Medical College,Zhangjing 524001,Guangdong,China
  • Received:2003-02-26 Revised:2003-04-14 Online:2003-08-26 Published:2020-11-19

Abstract: AIM: To investigate the effects and safe oflow molecular weight heparins(lMWH)in the treatment ofPatients with chronicPulmonary heart diseases(CPHD)at hypercoagulability state.METHODS: 65Patients were randomly assigned to treatment grouP(n =33)and control grouP(n =32).AllPatients were given routine treatments.ThePatients of treatment grouPwere hypodermically injected with 4 100~6 150 U oflMWHPer day for 7 days as a course.RESULTS: After 7 days of the treatments,thePatients of treatment grouPshowed better curative effect and significantly increase inPaO2and AT-III and decrease inPaCO2and FIB in comparison with thePatients in control grouP(P<0.05).CONCLUSION: LMWH is an effective agent in treatment ofPatients with CPHD.

Key words: pharmacodynamics, chronicPulmonary heart diseases, hypercoagulability state, low molecular weight heparins

CLC Number: